RT Book, Section
A1 Poole, Claudette L.
A1 Kimberlin, David W.
A2 Shah, Samir S.
A2 Kemper, Alex R.
A2 Ratner, Adam J.
SR Print(0)
ID 1157319931
T1 Antiviral Agents
T2 Pediatric Infectious Diseases: Essentials for Practice, 2e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259861536
LK accesspediatrics.mhmedical.com/content.aspx?aid=1157319931
RD 2024/04/20
AB Antiviral  medications  have  been  in  use  for  more  than  50  years,  but  it  was  the  rapid  expansion  of  new  agents  coming  to  market  since  the  1990s  that  brought  their  use  to  the  generalist  pediatrician  and  other  providers.  In  the  last  two  decades,  there  have  been  several  landmark  placebo-controlled  clinical  studies  evaluating  antiviral  medications  specifically  for  neonatal  viral  diseases,  most  notably  for  neonatal  herpes  simplex  virus  (HSV)  infection1,2  and  symptomatic  congenital  cytomegalovirus  (CMV)  infection3  that  have  dramatically  changed  the  management  and  outcomes  of  these  conditions.